Hospital Corporation of China Limited (HKG:3869)
Hong Kong · Delayed Price · Currency is HKD
3.500
+0.200 (6.06%)
Apr 10, 2026, 3:57 PM HKT
Revenue by Segment
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
Hospital Management Services | 390.85M | - | 257.86M | 191.09M | 232.22M | | | | | |
Hospital Management Services Growth | - | - | 34.94% | -17.71% | 2.35% | | | | | |
General Hospital Services | 1.41B | 1.30B | 1.33B | 1.05B | 302.45M | | | | | |
General Hospital Services Growth | 8.23% | -1.72% | 25.91% | 248.28% | 76.59% | | | | | |
| 3.07M | 5.82M | 3.06M | 850.00K | - | | | | | |
| -47.28% | 90.19% | 259.76% | - | - | | | | | |
| -343.38M | -292.13M | -170.94M | -113.48M | -18.76M | | | | | |
Sale of Pharmaceutical Products | 9.77M | - | 11.48M | 11.12M | 4.38M | | | | | |
Sale of Pharmaceutical Products Growth | - | - | 3.16% | 154.26% | 313.13% | | | | | |
| 1.47B | 1.02B | 1.43B | 1.14B | 520.29M | | | | | |
| 44.63% | -28.76% | 24.92% | 119.68% | 30.33% | | | | | |
Revenue by Geography
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
| 1.47B | 1.44B | 1.43B | 1.14B | 520.29M | | | | | |
| 1.99% | 1.02% | 24.92% | 119.68% | 30.33% | | | | | |
| 1.47B | 1.44B | 1.43B | 1.14B | 520.29M | | | | | |
| 1.99% | 1.02% | 24.92% | 119.68% | 30.33% | | | | | |
Source: S&P Global Market Intelligence.